Abstract
Tuberculosis (TB) is an airborne communicable disease. It is a new major health problem worldwide, with an increasing incidence in both developing and industrialized nations. The WHO reports that there are 2 million deaths related to TB per year. Ocular TB presents with varied manifestations, such as tubercular anterior uveitis, choroidal tubercle, subretinal abscess, multifocal choroiditis, retinal vasculitis or even panophthalmitis. The incidence of ocular complications due to TB has increased due to the coexistence of AIDS in those patients. Treatment of ocular TB should be concomitant with the management of systemic status. Multidrug-resistant TB has emerged as a new problem in the management of TB. Recognition of the correct diagnosis and specific therapy avoids recurrences and prevents ocular morbidity due to complications of TB.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.